Jane Street’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.5M | Buy |
558,392
+429,101
| +332% | +$11.9M | ﹤0.01% | 626 |
|
|
2025
Q1 | $2.87M | Sell |
129,291
-60,161
| -32% | -$1.34M | ﹤0.01% | 1895 |
|
|
2024
Q4 | $3.75M | Sell |
189,452
-155,640
| -45% | -$3.08M | ﹤0.01% | 1404 |
|
|
2024
Q3 | $8.62M | Buy |
345,092
+315,456
| +1,064% | +$7.88M | ﹤0.01% | 855 |
|
|
2024
Q2 | $553K | Buy |
29,636
+16,722
| +129% | +$312K | ﹤0.01% | 4418 |
|
|
2024
Q1 | $255K | Sell |
12,914
-46,987
| -78% | -$927K | ﹤0.01% | 4790 |
|
|
2023
Q4 | $1.05M | Buy |
59,901
+49,753
| +490% | +$873K | ﹤0.01% | 3267 |
|
|
2023
Q3 | $176K | Sell |
10,148
-16,271
| -62% | -$283K | ﹤0.01% | 4459 |
|
|
2023
Q2 | $372K | Buy |
+26,419
| New | +$372K | ﹤0.01% | 4045 |
|
|
2022
Q4 | – | Sell |
-11,194
| Closed | -$144K | – | 5901 |
|
|
2022
Q3 | $144K | Sell |
11,194
-29,665
| -73% | -$382K | ﹤0.01% | 4749 |
|
|
2022
Q2 | $396K | Buy |
40,859
+18,128
| +80% | +$176K | ﹤0.01% | 3802 |
|
|
2022
Q1 | $226K | Buy |
+22,731
| New | +$226K | ﹤0.01% | 4609 |
|
|
2021
Q4 | – | Sell |
-17,921
| Closed | -$204K | – | 5670 |
|
|
2021
Q3 | $204K | Buy |
+17,921
| New | +$204K | ﹤0.01% | 4375 |
|
|
2020
Q4 | – | Sell |
-10,599
| Closed | -$162K | – | 4163 |
|
|
2020
Q3 | $162K | Buy |
+10,599
| New | +$162K | ﹤0.01% | 3307 |
|